Predictors of Adherence Among Patients With Multiple Sclerosis Using the BETACONNECT(®) Autoinjector: A Prospective Observational Cohort Study

Background: In patients with multiple sclerosis (MS), non-adherence to disease-modifying drug therapy is associated with an increased rate of MS relapses. Early identification of patients at risk of non-adherence would allow provision of timely and individualized support. The aim of the BETAPREDICT...

Descripción completa

Detalles Bibliográficos
Autores principales: Köhler, Wolfgang, Bayer-Gersmann, Kirsten, Neußer, Thomas, Schürks, Markus, Ziemssen, Tjalf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7943887/
https://www.ncbi.nlm.nih.gov/pubmed/33716945
http://dx.doi.org/10.3389/fneur.2021.643126

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7943887/
https://www.ncbi.nlm.nih.gov/pubmed/33716945
http://dx.doi.org/10.3389/fneur.2021.643126

Ejemplares similares